A randomized pilot clinical trial of pravastatin versus placebo in pregnant patients at high risk of preeclampsia

Preeclampsia remains a major cause of maternal and neonatal morbidity and mortality. Biologic plausibility, compelling preliminary data, and a pilot clinical trial support the safety and utility of pravastatin for the prevention of preeclampsia.

Source: American Journal of Obstetrics and Gynecology - May 21, 2021 Category: OBGYN Authors: Maged M. Costantine, Holly West, Katherine L. Wisner, Steve Caritis, Shannon Clark, Raman Venkataramanan, Catherine S. Stika, Erik Rytting, Xiaoming Wang, Mahmoud S. Ahmed, Eunice Kennedy Shriver National Institute of Child Health and Human Development Ob Tags: Original Research Source Type: research